Trial Site Detail
Drug: |
CB-839 + Talazoparib |
|||
|---|---|---|---|---|
Trial: |
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
|||
Massachusetts General Hospital55 Fruit Street |
Principal Investigator: |
Richard Lee, MD |
|---|---|
Contact: |
Contact: Richard Lee, MD 617-724-4000 rjlee@partners.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Massachusetts General Hospital Website: |
http://www2.massgeneral.org/cancer/clinical_trials/adult/search_trials.asp |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.